Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Year: 2018

Results of NR and pterostilbene clinical trial are promising.

A clinical trial of an NR and pterostilbene anti-aging supplement appeared to be safe over the short-term as it increased NAD levels in a sustained way. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman. ]

A clinical trial of NR and pterostilbene sustainably increased NAD levels and appeared to be safe over the short-term. Moreover, the study suggests that it increased the mobility of the aging test subjects.

Our NAD levels decline as we age, and as the theory goes, boosting NAD will also increase our energy and keep our bodies in better condition.

Read more

Could a protein called klotho block aging and dementia?

Summary: More klotho means better cognitive function says a scientist. By injecting the protein Klotho into mice with Alzheimer’s, a UCSF researcher improved their brain function. The researcher hopes to eventually apply the treatment to humans to treat aging and dementia. [Introduction by Brady Hartman, followed by a link to the full article.]

Neurologist and neuroscientist Dr. Dena Dubal wants to prevent dementia and aging with a protein called Klotho. Dr. Dubal, MD, Ph.D. – an associate professor of neurology at UC San Francisco – aims to use this novel approach to battle neurodegenerative diseases like Alzheimer’s disease and dementia.

Rather than battle these diseases head-on, professor Dubal aims to block the aging process itself. Dr. Dubal is testing the protein’s potential as a therapeutic. The researcher found that by administering the protein to mice, she gave them a cognitive boost, equivalent to genetically increasing klotho. In fact, after injecting the protein into mice that had a condition similar to Alzheimer’s, Dr. Dubal remarked.

Read more

Researchers solved a problem that has been holding back the use of viral vectors for cancer therapy. They re-engineered viruses with a novel stealth technique that enables them to be used to treat cancer.

Up until now, viral vectors couldn’t be used widely in cancer therapy. Researchers just announced that they re-engineered an adenovirus with a novel stealth technique that enables it to be used to fight tumors. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman. ]

Viral vectors are well-developed tools used by scientists to deliver genetic material into cells. Unfortunately, they haven’t worked well to treat cancer until a group of researchers in Switzerland re-engineered them to enable them to be used in cancer therapy.

Researchers from the University of Zurich have re-engineered an adenovirus for use in cancer therapy. To achieve this, scientists developed a new protein shield that hides the virus and protects it from being eliminated by the body. Moreover, adapters on the surface of the virus enable the reconstructed virus to target and infect tumor cells.

Read more

When developing any personal health and longevity strategy it is essential to apply the scientific method.

There is one common public reaction to my talks that bothers me quite a bit. I am worried that after each of my lectures, people will just start taking lots of anti-aging pills without regard for dosage or effectiveness, potentially hurting themselves in the process.

This is because one of the most common reactions to me mentioning any currently available interventions is to search for each and every component and order them all right away. Whatever I say about safety and the need to test before people make any changes in their lifestyles seems ineffective.

So, I want to talk about this problem.

Read more

Idiopathic pulmonary fibrosis is a disease associated with critically short telomeres, and it currently lacks a reliable and effective treatment. Researchers at the Telomere and Telomerase Group at the Spanish National Cancer Research Centre (CNIO) have cured the disease in mice using telomerase therapy to lengthen short telomeres.

A proof of concept for an effective treatment against pulmonary fibrosis

The authors of this study have stated that this is a “proof of concept that telomerase activation represents an effective treatment against pulmonary fibrosis” in their publication[1].

Read more

The Chinese “Micius” satellite has successfully set up the world’s most secure video conference, using quantum cryptography to connect scientists in Europe and China for an unhackable, intercontinental chat.

The feat marks another milestone for the satellite, officially called Quantum Experiments at Space Scale (QESS), which only last year was making headlines for transmitting an “unbreakable” quantum code to the Earth’s surface.

Read more

At least the world knows what it is like to live in the shadow of nuclear weapons. There are much bigger question-marks over how the rapid advances in artificial intelligence (AI) and deep learning will affect the way wars are fought, and perhaps even the way people think of war. The big concern is that these technologies may create autonomous weapons systems that can make choices about killing humans independently of those who created or deployed them.

War is still a contest of wills, but technology and geopolitical competition are changing its character, argues Matthew Symonds.

Read more

Imagine a police car that issues tickets without even pulling you over.

What if the same car could use artificial intelligence to find good hiding spots to catch traffic violators and identify drivers by scanning license plates, tapping into surveillance cameras and wirelessly accessing government records?

What if a police officer tapping on your car window asking for your license and registration became a relic of transportation’s past?

Read more

US and UK military personnel, a think tank and a former GCHQ director have warned that the world’s intricate web of undersea internet cables is at risk.

Read more